CM Fadnavis Adds MD Drug Precursor to Schedule A Controls
Synopsis
Key Takeaways
Maharashtra Chief Minister Devendra Fadnavis announced on Friday, 10 July 2026, that the chemical used in the manufacture of MD drugs has been included in Schedule A of controlled substances under Maharashtra's drug regulatory framework, a move aimed at curbing the illicit trade in mephedrone and related synthetic narcotics. The announcement was made from the floor of the Maharashtra Legislative Assembly, Mumbai, during the ongoing Monsoon Session 2026.
Context
Speaking in the assembly, CM Fadnavis stated — in both English and Marathi — that the precursor chemical central to MD drug production has now been formally classified under Schedule A of controlled substances. In his words: 'एमडी ड्रग्ज निर्मितीसाठी वापरल्या जाणाऱ्या रसायनाचा शेड्युल A मधील नियंत्रित पदार्थांमध्ये समावेश' — meaning, 'the chemical used in the manufacture of MD drugs has been included among Schedule A controlled substances.' The classification is expected to impose stricter licensing, tracking, and trade restrictions on the chemical in question.
MD drugs — a street name for mephedrone, a synthetic stimulant — have been a persistent law-enforcement concern in Maharashtra, particularly in Mumbai and its satellite cities. Seizures of the substance have featured prominently in state police records over the past several years, making precursor control a long-demanded measure by enforcement agencies.
Policy Backdrop
India's primary legal framework for narcotics control is the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985, subsequently amended in 2001 and 2014, which established schedules for both controlled substances and their precursor chemicals. Schedule A classification typically subjects a chemical to the most stringent controls, including mandatory record-keeping by manufacturers, restrictions on sale and transfer, and enhanced penalties for violations.
Indian states periodically update their own enforcement frameworks in alignment with central NDPS rules to respond to emerging synthetic drug trends. The inclusion of a precursor chemical in Schedule A closes a regulatory gap that illicit manufacturers have historically exploited — procuring chemicals legally before converting them into prohibited narcotics.
Stakeholders and Impact
Law enforcement agencies across Maharashtra stand to gain a sharper legal instrument: once a precursor is scheduled, its unauthorised possession or trade becomes independently prosecutable, even before a finished narcotic is detected. This allows police and the Anti-Narcotics Cell to intervene earlier in the supply chain.
Chemical manufacturers and traders dealing in the now-scheduled substance will be required to comply with new documentation and licensing obligations. Industry bodies representing the chemicals sector may seek clarity on implementation timelines and the specific compound named in the gazette notification.
What's Next
The operative detail to watch is the official gazette notification that will name the exact chemical added to Schedule A and specify the effective date of enforcement. That notification will also define the penalties applicable to violations and the compliance window for existing traders.
Subsequent enforcement actions — raids, prosecutions, and seizure data — will determine whether the scheduling translates into a measurable reduction in MD drug availability on Maharashtra's streets. The Monsoon Session 2026 may see further legislative measures as the state government signals a broader push against synthetic drug networks.